{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:14:26Z","timestamp":1792782866732,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T00:00:00Z","timestamp":1676246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971545"],"award-info":[{"award-number":["81971545"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071839"],"award-info":[{"award-number":["82071839"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2020-I2M-C\uff06T-A-002"],"award-info":[{"award-number":["2020-I2M-C\uff06T-A-002"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["CIFMS 2021-1-I2M-003"],"award-info":[{"award-number":["CIFMS 2021-1-I2M-003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s10067-023-06528-5","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T15:08:47Z","timestamp":1676300927000},"page":"1839-1846","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of the efficacy and safety of leflunomide versus mycophenolate mofetil in treating IgG4-related disease: a retrospective cohort study"],"prefix":"10.1007","volume":"42","author":[{"given":"Yingying","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianmin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-7376","authenticated-orcid":false,"given":"Yunyun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,13]]},"reference":[{"issue":"9976","key":"6528_CR1","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH (2015) IgG4-related disease. Lancet (London England) 385(9976):1460\u20131471","journal-title":"Lancet (London England)"},{"issue":"10","key":"6528_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K et al (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38(10):982\u2013984","journal-title":"J Gastroenterol"},{"issue":"2","key":"6528_CR3","first-page":"239","volume":"73","author":"W Van Moerkercke","year":"2010","unstructured":"Van Moerkercke W, Verhamme M, Doubel P, Meeus G, Oyen R, Van Steenbergen W (2010) Autoimmune pancreatitis and extrapancreatic manifestations of IgG4-related sclerosing disease. Acta Gastro-Enterol Belg 73(2):239\u2013246","journal-title":"Acta Gastro-Enterol Belg"},{"issue":"13","key":"6528_CR4","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.4103\/0366-6999.184459","volume":"129","author":"Y Chen","year":"2016","unstructured":"Chen Y, Zhao JZ, Feng RE, Shi JH, Li XM, Fei YY et al (2016) Types of organ involvement in patients with immunoglobulin G4-related disease. Chin Med J 129(13):1525\u20131532","journal-title":"Chin Med J"},{"issue":"5","key":"6528_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/PAP.0b013e3181ee63ce","volume":"17","author":"W Cheuk","year":"2010","unstructured":"Cheuk W, Chan JK (2010) IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 17(5):303\u2013332","journal-title":"Adv Anat Pathol"},{"issue":"7","key":"6528_CR6","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN et al (2015) International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol (Hoboken NJ) 67(7):1688\u20131699","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"issue":"1","key":"6528_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/BOR.0b013e328341a240","volume":"23","author":"A Khosroshahi","year":"2011","unstructured":"Khosroshahi A, Stone JH (2011) Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 23(1):67\u201371","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"6528_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40266-018-0534-6","volume":"35","author":"M Akiyama","year":"2018","unstructured":"Akiyama M, Takeuchi T (2018) IgG4-related disease: beyond glucocorticoids. Drugs Aging 35(4):275\u2013287","journal-title":"Drugs Aging"},{"issue":"11","key":"6528_CR9","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR et al (2013) Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 62(11):1607\u20131615","journal-title":"Gut"},{"issue":"1","key":"6528_CR10","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","volume":"7","author":"F Yunyun","year":"2017","unstructured":"Yunyun F, Yu C, Panpan Z, Hua C, Di W, Lidan Z et al (2017) Efficacy of cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids. Sci Rep 7(1):6195","journal-title":"Sci Rep"},{"issue":"1","key":"6528_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/rheumatology\/key227","volume":"58","author":"F Yunyun","year":"2019","unstructured":"Yunyun F, Yu P, Panpan Z, Xia Z, Linyi P, Jiaxin Z et al (2019) Efficacy and safety of low dose mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial. Rheumatology (Oxford) 58(1):52\u201360","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"6528_CR12","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/1756-185X.13633","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang P, Gong Y, Liu Z, Liu Y, Lin W, Li J et al (2019) Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: a prospective clinical trial. Int J Rheum Dis 22(8):1479\u20131488","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"6528_CR13","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.semarthrit.2020.01.010","volume":"50","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhao Z, Gao D, Wang H, Liao S, Dong C et al (2020) Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: a randomized clinical trial. Semin Arthritis Rheum 50(6):1513\u20131520","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"6528_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/imj.13430","volume":"47","author":"Y Wang","year":"2017","unstructured":"Wang Y, Li K, Gao D, Luo G, Zhao Y, Wang X et al (2017) Combination therapy of leflunomide and glucocorticoids for the maintenance of remission in patients with IgG4-related disease: a retrospective study and literature review. Intern Med J 47(6):680\u2013689","journal-title":"Intern Med J"},{"issue":"10","key":"6528_CR15","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1093\/rheumatology\/kev244","volume":"54","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Campochiaro C, Bozzolo EP, Dagna L, Scotti R, Nicoletti R et al (2015) Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford) 54(10):1934\u20131936","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"6528_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.cgh.2009.03.021","volume":"7","author":"NS Sandanayake","year":"2009","unstructured":"Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z et al (2009) Presentation and management of post-treatment relapse in autoimmune pancreatitis\/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 7(10):1089\u20131096","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"6528_CR17","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ et al (2008) Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 134(3):706\u2013715","journal-title":"Gastroenterology"},{"issue":"4","key":"6528_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1445-5994.2012.02964.x","volume":"43","author":"JJ Bosco","year":"2013","unstructured":"Bosco JJ, Suan D, Varikatt W, Lin MW (2013) Extra-pancreatic manifestations of IgG4-related systemic disease: a single-centre experience of treatment with combined immunosuppression. Intern Med J 43(4):417\u2013423","journal-title":"Intern Med J"},{"issue":"6","key":"6528_CR19","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1055\/s-0034-1366331","volume":"52","author":"M Buechter","year":"2014","unstructured":"Buechter M, Klein CG, Kloeters C, Schlaak JF, Canbay A, Gerken G et al (2014) Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis. Z Gastroenterol 52(6):564\u2013568","journal-title":"Z Gastroenterol"},{"issue":"1","key":"6528_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T et al (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22(1):21\u201330","journal-title":"Mod Rheumatol"},{"key":"6528_CR21","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers MN, Stone JH, Deshpande V, Khosroshahi A (2012) Development of an IgG4-RD responder index. Int J Rheumatol 2012:259408","journal-title":"Int J Rheumatol"},{"key":"6528_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3389\/fmed.2020.00253","volume":"7","author":"X Luo","year":"2020","unstructured":"Luo X, Peng Y, Zhang P, Li J, Liu Z, Lu H et al (2020) Comparison of the effects of cyclophosphamide and mycophenolate mofetil treatment against immunoglobulin G4-related disease: a retrospective cohort study. Front Med 7:253","journal-title":"Front Med"},{"issue":"6","key":"6528_CR23","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","volume":"75","author":"C Strehl","year":"2016","unstructured":"Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M et al (2016) Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Ann Rheum Dis 75(6):952\u2013957","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"6528_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00535-014-0942-2","volume":"49","author":"K Okazaki","year":"2014","unstructured":"Okazaki K, Kawa S, Kamisawa T, Ito T, Inui K, Irie H et al (2014) Amendment of the Japanese Consensus Guidelines for autoimmune pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 49(4):567\u201388","journal-title":"J Gastroenterol"},{"issue":"11","key":"6528_CR25","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gut.2008.172908","volume":"58","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa T, Shimosegawa T, Okazaki K, Nishino T, Watanabe H, Kanno A et al (2009) Standard steroid treatment for autoimmune pancreatitis. Gut 58(11):1504\u20131507","journal-title":"Gut"},{"issue":"2","key":"6528_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro C, Ramirez GA, Bozzolo EP, Lanzillotta M, Berti A, Baldissera E et al (2016) IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand J Rheumatol 45(2):135\u2013145","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"6528_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41584-020-0374-8","volume":"16","author":"JCA Broen","year":"2020","unstructured":"Broen JCA, van Laar JM (2020) Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology. Nat Rev Rheumatol 16(3):167\u2013178","journal-title":"Nat Rev Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06528-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06528-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06528-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T05:25:28Z","timestamp":1686720328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06528-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,13]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["6528"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06528-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,13]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Ethics Committee of the Peking Union Medical College Hospital (Number: S-442) and was conducted in accordance with the Helsinki Declaration. Written informed consent was obtained from all patients included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript is approved by all authors for publication, and written informed consent to publish was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}